Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy [version 3; referees: 2 approved, 1 approved with reservations]

Background: The piracetam analog, aniracetam, has recently received attention for its cognition enhancing potential, with minimal reported side effects.  Previous studies report the drug to be effective in both human and non-human models with pre-existing cognitive dysfunction, but few studies have...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Conner D. Reynolds, Taylor S. Jefferson, Meagan Volquardsen, Ashvini Pandian, Gregory D. Smith, Andrew J. Holley, Joaquin N. Lugo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: F1000 Research Ltd 2018-06-01
Reeks:F1000Research
Onderwerpen:
Behavioral Neuroscience
Cognitive Neuroscience
Online toegang:https://f1000research.com/articles/6-1452/v3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items